Actinomycosis: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
Name = {{PAGENAME}} | | Name = {{PAGENAME}} | | ||
Image = Actinomycosis.jpg | | Image = Actinomycosis.jpg | | ||
Caption = A patient with Actinomycosis on the right side of the face. | | Caption = A patient with Actinomycosis on the right side of the face. | | ||
{{About1|Actinomyces israelii}} | {{About1|Actinomyces israelii}} | ||
'''For patient information click [[Actinomycosis(patient information)|here]]''' | |||
DiseasesDB = 145 | | DiseasesDB = 145 | | ||
ICD10 = {{ICD10|A|42||a|30}} | | ICD10 = {{ICD10|A|42||a|30}} | |
Revision as of 13:18, 31 July 2015
For patient information click here
Actinomycosis | |
A patient with Actinomycosis on the right side of the face. | |
ICD-10 | A42 |
ICD-9 | 039 |
MeSH | D000196 |
Actinomycosis Microchapters |
Diagnosis |
---|
Treatment |
Actinomycosis On the Web |
American Roentgen Ray Society Images of Actinomycosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Actinomyces; actinomyces israeli;
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Actinomycosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
- Actinomyces species including A. israeli[1]
- Preferred regimen: Penicillin 3-4 million units IV q4h for 2-6 weeks THEN Penicillin V 2-4 g/day PO qid for 6-12 months
- Alternative regimen (1): Erythromycin 500-1000 mg IV q6h OR 500 mg PO qid
- Alternative regimen (2): Tetracyclin 500 mg PO qid
- Alternative regimen (3): Doxycycline 100 mg IV q12h OR 100 mg PO bid
- Alternative regimen (4): Clindamycin 900 mg IV q8h OR 300-450 mg PO qd
- Alternative regimen (5): Minocycline 100 mg IV q12h OR 100 mg PO bid
Acknowledgements
The content on this page was first contributed by: Dr. Steve Wiviott
References
- ↑ Bennett, John (2015). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. Philadelphia, PA: Elsevier/Saunders. ISBN 978-1455748013.
de:Aktinomykose gl:Actinomicose hr:Aktinomikoza nl:Actinomycose sr:Актиномикоза fi:Aktinomykoosi uk:Актиномікоз